BioTelemetry (BEAT) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free BEAT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesShort InterestSocial MediaStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesShort InterestSocial Media BioTelemetry Short Interest DataCurrent Short Volume138,700 sharesPrevious Short Volume159,400 sharesChange Vs. Previous Month-12.99%Dollar Volume Sold Short$255,208.00Short Interest Ratio / Days to Cover1.1Last Record DateApril 15, 2024Outstanding Shares26,330,000 sharesFloat Size19,490,000 sharesShort Percent of Float0.71%Today's Trading Volume73,606 sharesAverage Trading Volume64,257 sharesToday's Volume Vs. Average115% Short Selling BioTelemetry ? Sign up to receive the latest short interest report for BioTelemetry and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBEAT Short Interest Over TimeBEAT Days to Cover Over TimeBEAT Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him BioTelemetry Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024138,700 shares $255,208.00 -13.0%0.7%1.1 $1.84 3/31/2024159,400 shares $347,492.00 +20.7%0.8%1.2 $2.18 3/15/2024132,100 shares $318,361.00 +247.6%0.7%0.4 $2.41 2/29/202438,000 shares $55,100.00 -13.8%0.2%0.1 $1.45 2/15/202444,100 shares $79,380.00 +13.4%0.2%0.2 $1.80 1/31/202438,900 shares $72,743.00 -37.3%0.2%0.2 $1.87 Get the Latest News and Ratings for BEAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioTelemetry and its competitors with MarketBeat's FREE daily newsletter. 1/15/202462,000 shares $104,160.00 -62.3%0.3%0.3 $1.68 12/31/2023164,500 shares $386,575.00 +383.8%0.8%0.7 $2.35 12/15/202334,000 shares $42,500.00 +21.9%0.2%0.2 $1.25 11/30/202327,900 shares $40,455.00 -44.6%0.1%0.5 $1.45 11/15/202350,400 shares $61,488.00 +3.9%0.3%0.9 $1.22 10/31/202348,500 shares $60,140.00 -12.8%0.3%0.9 $1.24 10/15/202355,600 shares $81,732.00 -25.0%0.3%1.1 $1.47 9/30/202374,100 shares $159,315.00 -3.9%0.4%1.2 $2.15 9/15/202377,100 shares $189,666.00 +15.9%0.4%0.9 $2.46 8/31/202366,500 shares $138,985.00 -14.9%0.4%0.6 $2.09 8/15/202378,100 shares $194,469.00 -40.1%0.4%0.2 $2.49 7/31/2023130,400 shares $396,416.00 -18.9%2.2%0.3 $3.04 7/15/2023160,700 shares $515,847.00 +31.5%2.7%0.3 $3.21 6/30/2023122,200 shares $294,502.00 -4.8%2.0%0.2 $2.41 6/15/2023128,300 shares $346,410.00 -29.6%2.1%0.3 $2.70 5/31/2023182,200 shares $428,170.00 +103.8%16.7%0.4 $2.35 5/15/202389,400 shares $193,998.00 No Change3.8%1.3 $2.17 10/31/2022347,000 shares $1.16 million -5.0%9.3%0.1 $3.33 10/15/2022365,400 shares $1.41 million -29.5%9.7%0.1 $3.87 9/30/2022518,000 shares $2.02 million +1,367.4%13.8%0.1 $3.90 9/15/202235,300 shares $81,896.00 -46.1%0.9%0 $2.32 8/31/202265,500 shares $83,840.00 +26.2%1.8%0.7 $1.28 8/15/202251,900 shares $80,445.00 -38.5%1.4%0.6 $1.55 7/31/202284,400 shares $119,004.00 +8.3%2.3%1.2 $1.41 7/15/202277,900 shares $105,944.00 -7.2%2.1%1.1 $1.36 6/30/202283,900 shares $108,231.00 -17.8%2.1%0.5 $1.29 6/15/2022102,000 shares $132,600.00 -5.9%2.6%0.7 $1.30 5/31/2022108,400 shares $157,180.00 +43.6%2.7%0.7 $1.45 5/15/202275,500 shares $101,925.00 -34.9%1.9%0.5 $1.35 4/30/2022115,900 shares $158,783.00 +26.7%3.0%0.7 $1.37 4/15/202291,500 shares $147,315.00 -13.2%2.4%0.5 $1.61 3/31/2022105,400 shares $194,357.60 +100.4%N/A1 $1.84 3/15/202252,600 shares $87,842.00 +9.1%1.4%0.2 $1.67 2/28/202248,200 shares $84,350.00 -32.8%1.3%0.2 $1.75A.I. is a Tidal Wave - Here’s What to Buy (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. BEAT Short Interest - Frequently Asked Questions What is BioTelemetry's current short interest? Short interest is the volume of BioTelemetry shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 138,700 shares of BEAT short. 0.71% of BioTelemetry's shares are currently sold short. Learn More on BioTelemetry's current short interest. What is a good short interest ratio for BioTelemetry? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAT shares currently have a short interest ratio of 1.0. Learn More on BioTelemetry's short interest ratio. What is a good short interest percentage for BioTelemetry? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.71% of BioTelemetry's floating shares are currently sold short. Is BioTelemetry's short interest increasing or decreasing? BioTelemetry saw a decrease in short interest in April. As of April 15th, there was short interest totaling 138,700 shares, a decrease of 13.0% from the previous total of 159,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioTelemetry's float size? BioTelemetry currently has issued a total of 26,330,000 shares. Some of BioTelemetry's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioTelemetry currently has a public float of 19,490,000 shares. How does BioTelemetry's short interest compare to its competitors? 0.71% of BioTelemetry's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to BioTelemetry: IceCure Medical Ltd (1.50%), Apyx Medical Co. (1.31%), Daxor Co. (0.62%), SEP Acquisition Corp. (0.35%), Sensus Healthcare, Inc. (0.26%), Cytosorbents Co. (2.85%), Lucid Diagnostics Inc. (2.53%), DarioHealth Corp. (4.65%), Pro-Dex, Inc. (0.91%), Monogram Orthopaedics, Inc. (2.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BioTelemetry stock? Short selling BEAT is an investing strategy that aims to generate trading profit from BioTelemetry as its price is falling. BEAT shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioTelemetry? A short squeeze for BioTelemetry occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAT, which in turn drives the price of the stock up even further. How often is BioTelemetry's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: IceCure Medical Short Interest Apyx Medical Short Interest Daxor Short Interest SEP Acquisition Short Interest Sensus Healthcare Short Interest Cytosorbents Short Interest Lucid Diagnostics Short Interest DarioHealth Short Interest Pro-Dex Short Interest Monogram Orthopaedics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BEAT) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Nvidia. This is the future of AIPorter & CompanyAI “wealth window” is closing June 25thParadigm Press